ICU MEDICAL INC/DEICUIEarnings & Financial Report
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, a...
ICUI Q3 2025 Key Financial Metrics
Revenue
$537.0M
Gross Profit
$200.9M
Operating Profit
$13.7M
Net Profit
$-3.4M
Gross Margin
37.4%
Operating Margin
2.6%
Net Margin
-0.6%
YoY Growth
-8.9%
EPS
$-0.14
Financial Flow
ICU MEDICAL INC/DE Q3 2025 Financial Summary
ICU MEDICAL INC/DE reported revenue of $537.0M for Q3 2025, with a net profit of $-3.4M (-0.6% margin). Cost of goods sold was $336.1M, operating expenses totaled $187.2M.
Key Financial Metrics
| Total Revenue | $537.0M |
|---|---|
| Net Profit | $-3.4M |
| Gross Margin | 37.4% |
| Operating Margin | 2.6% |
| Report Period | Q3 2025 |
ICU MEDICAL INC/DE Annual Revenue by Year
ICU MEDICAL INC/DE annual revenue history includes year-by-year totals (for example, 2024 revenue was $2.4B).
| Year | Annual Revenue |
|---|---|
| 2024 | $2.4B |
| 2023 | $2.3B |
| 2022 | $2.3B |
Income Statement
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $587.9M | $566.7M | $596.5M | $589.1M | $629.8M | $604.7M | $548.9M | $537.0M |
| YoY Growth | 1.7% | -0.4% | 8.6% | 6.5% | 7.1% | 6.7% | -8.0% | -8.9% |
Balance Sheet
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $4.38B | $4.29B | $4.29B | $4.31B | $4.20B | $4.18B | $4.11B | $4.10B |
| Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Equity | $2.12B | $2.07B | $2.04B | $2.05B | $1.97B | $1.99B | $2.12B | $2.13B |
Cash Flow
| Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $91.3M | $45.8M | $82.0M | $36.1M | $40.2M | $51.3M | $11.2M | $56.7M |